Igniting a Wellness Revolution: Unveiling Sfera NMN for Healthy Aging

Are you ready to step into a realm where the boundaries of ageing fade away, ushering in a new dawn of vitality? Brace yourself as we unveil our latest masterpiece – Sfera NMN! This revolutionary innovation is poised to reshape our journey towards thriving as we age. Join us on an expedition to uncover the very future of wellness and human potential.

A Glimpse into the Future

Imagine a world where energy and vibrancy know no age, and where your well-being takes centre stage. Sfera NMN is not just a supplement; it's a testament to the power of science and innovation.  Inspired by the groundbreaking research of Harvard University's esteemed longevity expert, Prof. David Sinclair, the discovery that NMN can elevate NAD+ levels offer a promising avenue to ensure healthy ageing. Declining NAD+ levels have been identified as a hallmark of ageing, and NMN holds the key to potentially rewiring this narrative (Shade, 2020).

Unveiling the Science Behind the Magic

At the core of Sfera NMN lies an intricate process of enzymatic conversion, perfected by scientists to ensure a high level of purity and potency. The result? A pristine beta-NMN molecule that is remarkably stable and perfectly suited for use in a Sfera product.

This is not just science; it's the alchemy of possibilities.

But what sets Sfera NMN apart goes beyond purity; it's about that exhilarating feeling of rejuvenation, embracing the forefront of healthy ageing science from some of the brightest minds in the world! Sfera NMN promises not only remarkable results but an experience that defies expectations. The specific NMN we use in our product has been shown in a clinical trial to increase the levels of NAD+ and according to the researchers was “linked to higher energy & anti-aging effects” (Huang, 2022).

The Pathway to Radiance

Picture this: you, at your absolute best, exuding a vitality that transcends time. Sfera NMN supports healthy ageing by boosting NAD+ levels, a coenzyme crucial for cellular energy and rejuvenation. As NAD+ levels decline with age, Sfera NMN swoops in as your secret weapon, replenishing and revitalising from within (Shade, 2020).

Published research underscores the profound effects of NMN on NAD+ levels, promoting improved quality of life scores and unlocking a vibrant existence. Imagine feeling zest coursing through your veins, empowering you to live life to the fullest (Yi, et al. 2023).

Your Invitation to Transform

Sfera NMN isn't just a supplement; it's an invitation to embrace a new way of living. Our commitment to quality and innovation is evident in every facet of this remarkable creation. With an impressive minimum 99% purity, third-party testing, and adherence to stringent quality standards, Sfera NMN is your passport to a future where well-being knows no boundaries.

Join us on the leading edge, a magical place where possibilities await when science and wellness converge. Welcome to a future redefined by vitality, energy, and a zest for life. Welcome to Sfera NMN – where age is just a number, and your well-being is the masterpiece.

The future of wellness is here, and it's yours for the taking.


Huang, H. (2022). A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults. Frontiers in Aging, 3. https://doi.org/10.3389/fragi.2022.851698

Schultz, M. B., & Sinclair, D. A. (2016). Why NAD(+) Declines during Aging: It's Destroyed. Cellular Metabolism23(6), 965–966. https://doi.org/10.1016/j.cmet.2016.05.022 

Shade C. (2020). The Science Behind NMN-A Stable, Reliable NAD+Activator and Anti-Aging Molecule. Integrative Medicine (Encinitas, Calif.)19(1), 12–14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238909/ 

Yoshino, J., Baur, J. A., & Imai, S. I. (2018). NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cellular Metabolism27(3), 513–528. https://doi.org/10.1016/j.cmet.2017.11.002 

Yi, L., Maier, A. B., Tao, R., Lin, Z., Vaidya, A., Pendse, S., Thasma, S., Andhalkar, N., Avhad, G., & Kumbhar, V. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience45(1), 29–43. https://doi.org/10.1007/s11357-022-00705-1